One Year Efficacy and Safety Results of a Phase II Trial of Secukinumab in Patients with Rheumatoid Arthritis.

被引：0
|
作者：
Genovese, Mark C. [1 ]
Durez, Patrick [2 ]
Richards, Hanno B. [3 ]
Supronik, Jerzy [4 ]
Dokoupilova, Eva [5 ]
Aelion, Jacob A. [6 ]
Lee, Sang-Heon [7 ]
Codding, Christine E. [8 ]
Kellner, Herbert [9 ]
Ikawa, Takashi [10 ]
Hugot, Sophie [3 ]
Ligozio, Gregory [11 ]
Mpofu, Shephard [3 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[3] Novartis Pharma AG, Basel, Switzerland
[4] NZOZ Ctr Med Artur Racewicz, Bialystok, Poland
[5] Med Plus Sro, Uherske Hradiste, Czech Republic
[6] Arthrit Clin, Jackson, TN USA
[7] Konkuk Univ Med Ctr, Seoul, South Korea
[8] Hlth Res Oklahoma, Oklahoma City, OK USA
[9] Ctr Inflammatory Joint Dis, Munich, Germany
[10] Kobe Konan Yamate Clin, Kobe, Hyogo, Japan
[11] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
401
引用
收藏
页码：S149 / S150
页数：2
相关论文
共 50 条
  • [31] Therapeutic trial with type II oral collagen in rheumatoid arthritis.
    Neira, O
    Alvarado, A
    Cerda, C
    Guzman, L
    Abumohor, P
    Basualdo, J
    Palma, S
    Fuentealba, C
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 394 - 394
  • [32] EFFICACY AND SAFETY OF SECUKINUMAB TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Kriulin, I.
    Alexeeva, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Krekhova, E.
    Shingarova, M.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 485 - 485
  • [33] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin A.
    Park, Won
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Timothy A.
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S188 - S189
  • [34] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin
    Park, W.
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Tim
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 : 93 - 93
  • [35] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5-YEAR EFFICACY AND SAFETY RESULTS FROM THE FUTURE 1 PHASE 3 TRIAL
    Tahir, Hasan
    Mease, Philip J.
    Kavanaugh, Arthur
    Reimold, Andreas
    Rech, Juergen
    Hall, Stephen
    Geusens, Piet
    Pellet, Pascale
    Delicha, Eumorphia Maria
    Pricop, Luminita
    Mpofu, Shephard
    RHEUMATOLOGY, 2019, 58 : 151 - 151
  • [36] 5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial
    Marzo-Ortega, Helena
    Sieper, Joachim
    Kivitz, Alan J.
    Blanco, Ricardo
    Cohen, Martin
    Pavelka, Karel
    Delicha, Eumorphia M.
    Stefanska, Anna
    Richards, Hanno B.
    Rohrer, Susanne
    LANCET RHEUMATOLOGY, 2020, 2 (06): : E339 - E346
  • [37] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL
    Mease, P. J.
    Kavanaugh, A.
    Reimold, A.
    Tahir, H.
    Rech, J.
    Hall, S.
    Geusens, P.
    Pascale, P.
    Delicha, E. M.
    Pricop, L.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 952 - 953
  • [38] SAFETY AND EFFICACY OF ATACICEPT IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ATACICEPT FOR REDUCTION OF SIGNS AND SYMPTOMS IN RHEUMATOID ARTHRITIS TRIAL (III)
    van Vollenhoven, R. F.
    Wax, S.
    Copt, S.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 183 - 184
  • [39] Long-term efficacy and safety of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari, I
    Burgos-Vargas, R
    Thon, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S121 - S121
  • [40] Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial
    van Vollenhoven, Ronald F.
    Keystone, Edward Clark
    Strand, Vibeke
    Pacheco-Tena, Cesar
    Vencovsky, Jiri
    Behrens, Frank
    Racewicz, Arthur
    Zipp, Daniela
    Rharbaoui, Faiza
    Wolter, Ralf
    Knierim, Luise
    Schmeidl, Rainer
    Zhou, Xuefei
    Aigner, Silke
    Daelken, Benjamin
    Wartenberg-Demand, Andrea
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) : 495 - 499
12345